CN Stock MarketDetailed Quotes

Lionco Pharmaceutical Group (603669)

Watchlist
  • 4.43
  • -0.22-4.73%
Market Closed Apr 17 15:00 CST
3.20BMarket Cap-27.01P/E (TTM)

Lionco Pharmaceutical Group (603669) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Pharmaceutical circulation130.16M75.85%
Anti-infective class18.07M10.53%
Parenteral nutrition7.58M4.42%
Other income4.6M2.68%
Cardio-cerebrovascular class4.4M2.57%
Digestive system3.2M1.87%
医院销售及配送收入1.56M0.91%
rent out1.47M0.85%
其他药品类560.32K0.33%
View all

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry321.38M84.62%
Pharmaceutical circulation46.31M12.19%
Other business10.25M2.70%
医院销售及配送1.83M0.48%
Total special adjustments23--

By Country/Region

Currency:CNY
2024/FY
Stock NameRevenueRatio
Central China146.95M38.69%
East China146.36M38.54%
Southwest38.22M10.06%
North China14.77M3.89%
Northwest10.32M2.72%
Other business10.25M2.70%
Northeast China7.98M2.10%
South China4.93M1.30%
Total special adjustments23--
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On April 17, the Iranian foreign minister announced the opening of the Strait of Hormuz to merchant ships, and Trump immediately posted a me Show More